Tn5 transposase drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Tn5 transposase | associated_with | Illumina HiSeq 2000 | — | 1 |
Mentioned in (9)
Papers in which this entity is mentioned.
- Human Retrotransposons and Effective Computational Detection Methods for Next-Generation Sequencing Data. (2022)
- GATA4/5/6 family transcription factors are conserved determinants of cardiac versus pharyngeal mesoderm fate. (2022)
- Folding Keratin Gene Clusters during Skin Regional Specification. (2020)
- Genetic compensation triggered by mutant mRNA degradation. (2019)
- CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder. (2019)
- CUT&RUNTools: a flexible pipeline for CUT&RUN processing and footprint analysis. (2019)
- Impact of cytosine methylation on DNA binding specificities of human transcription factors. (2017)
- ATAC-seq: A Method for Assaying Chromatin Accessibility Genome-Wide. (2015)
- Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. (2010)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| tn5 transposase | drug | 9 | 11 |
| hyperactive tn5 transposase | drug | 1 | 1 |